Autism Spectrum Disorder

A clinical-stage biopharma firm announced it has been granted a U.S. patent expanding coverage of a novel oral therapy to treat various conditions associated with loss-of-function mutations of the gene encoding methyl-CpG binding protein.

A biotech startup that specializes in gene therapy for neurocognitive disorders has acquired the patents to detect autism spectrum disorder in newborns using a skin biopsy, according to a press release.

A study of more than 1 million children in Canada found that those who were born to women who used assisted conception methods were slightly more likely to be diagnosed with autism spectrum disorder than those who were not.

Children born to women with infertility who utilized assisted reproduction methods had slightly higher risk for autism spectrum disorder, independent of fertility treatment used, according to study results published in JAMA Network Open.

WASHINGTON — Training primary care physicians to evaluate children for autism could improve diagnosis, a study presented at the AAP National Conference & Exhibition found.

An app that correctly identified most cases of autism in children could help reduce disparities in early detection of the condition, according to the results of an NIH-funded study published in Nature Medicine.

PHILADELPHIA — Tracking to chart various eye movements including saccadic and fixation may be effective in differentiating neurological differences between children with ASD and neurotypical children, according to a poster presentation.

Children born to placentas with fetal inflammatory syndrome are more likely to be diagnosed with neuropsychiatric disorders, according to a study published in Translational Psychiatry.

A study of more than 50,000 children born over a 14-year period in Denmark found that children born to mothers who were exposed to higher levels of lithium in their drinking water were moderately more likely to develop autism.

Biopharmaceutical company Zelira Therapeutics has received $8.6 million in funding for the study of its cannabinoid drug for use in patients with autism spectrum disorder, according to a company press release.